8
Sep
2016
Diabetes drug focus of new clinical trial for Parkinson’s disease
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II... Read More
12
Jul
2016
Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease
Note: To read the commentary published in the Journal of Parkinson’s Disease click here. Investigators will focus on safety for long-term use in non-cancer... Read More
22
Feb
2016
Promising respiratory drug focus of new clinical trial for Parkinson’s disease
GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies... Read More
23
Sep
2014
Van Andel Research Institute joins The Cure Parkinson’s Trust to accelerate development of new Parkinson’s disease treatments
Grand Rapids, Mich. (Sept. 23, 2014) – Van Andel Research Institute (VARI) has partnered with UK-based research charity The Cure Parkinson’s Trust on... Read More